evidoria

← Back to browse

Good practice

KiwiNet — New Zealand's National Research-Commercialisation Network

New Zealand · Hamilton · See the New Zealand profile

Since 2011, KiwiNet has pooled New Zealand's university and Crown Research Institute commercialisation efforts, backing 82+ spin-outs and $560m in cumulative returns by 2024 — though its leadership warns under 1% of public research funding reaches commercialisation nationally.

KiwiNet — New Zealand's National Research-Commercialisation Network

Details

Promoter
Kiwi Innovation Network Limited (KiwiNet)
Period
2011-2024
Keywords
research commercialization, pre-seed funding, university-industry collaboration, startup creation

Description

KiwiNet (Kiwi Innovation Network Limited) was established in 2011 to pool New Zealand's government PreSeed Accelerator Fund and share commercialisation expertise nationally, building on UniCom, a 2008 consortium of four university tech-transfer offices. It is a shareholder company owned by New Zealand universities, Crown Research Institutes and other public research organisations, together representing roughly 80% of the country's publicly funded researchers.
KiwiNet's 2024 annual report (to 30 June 2024) records 82 start-up companies and $560 million in cumulative financial returns since 2011. An independent evaluation commissioned by New Zealand's Ministry of Business, Innovation and Employment (MBIE), conducted by Ridley Insights in 2014, found that 573 PreSeed-funded projects since 2004 had received NZ$42.6 million in government investment, matched by a further NZ$90.9 million in co-funding, generating 386+ licences plus start-ups and commercial deals. In its 2019 funding round, MBIE approved NZ$9,944,920 (excluding GST) over two years for KiwiNet. A named success story on KiwiNet's own site, Zincovery (a University of Canterbury spin-out founded 2021), received NZ$267,000 in PreSeed funding, has since raised NZ$20 million in total, and signed over NZ$500 million in global commercial agreements.
KiwiNet's own 2025 Shareholder Vision Statement is candid that 'less than 1% of public research funding goes toward commercialisation' in New Zealand, citing TTO funding instability, a shallow early-stage investment market, and system fragmentation as ongoing constraints — with the country's overall R&D spend sitting at roughly 0.95% of GDP, well below the government's 2% target. In 2026, KiwiNet's CEO publicly warned that new science-system funding reforms redirecting NZ$111 million toward 'advanced technology' by cutting other research budgets risk treating commercialisation 'as a zero-sum exercise' that undermines the upstream research pipeline it depends on.

Read the full analysis: https://kiwinet.org.nz/About

Implementation

Implementation detail (cost, timeline, staffing, conditions for success) is not yet available for this practice.

Data sources

Where this practice's information was retrieved from, and when.

Attachments

Similar practices you may find useful